Schmitz et al. [19] reported that MYD88 mutations frequently co-occur with CD79B mutations, forming the MCD (MYD88/CD79B) genetic subtype, observed in 71 out of 574 DLBCL cases. Here, MYD88 is linked to diffuse large B-cell lymphoma.